| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.3 |